Lawrence Wennogle - Intra Cellular Insider

Intra Cellular Therapies Inc -- USA Stock  

USD 15.87  0.12  0.75%

Vice President of Drug Discovery

Dr. Lawrence P. Wennogle Ph.D. is Vice President Drug Discovery of IntraCellular Therapies Inc. For the past 33 years Dr. Wennogle was involved in research and development in the pharmaceutical industry aimed at the discovery of novel pharmaceutical entities for human diseases. He was a Staff Scientist and Principal Research Fellow at CibaGeigy and Novartis Pharmaceutical Corporationrationration for 19 years where he led drug discovery programs for CNS disorders cardiovascular diseases diabetes and inflammation
Age: 65  President Since 2014  Ph.D    
212 923-3344
Wennogle received his B.A. from Ithaca College and his Ph.D. in Biochemistry from the University of Colorado, Boulder. He then completed two postdoctoral positions, one at the University of Colorado and the second at the Pasteur Institute in Paris, France, working under JeanPierre Changeux on the structurefunction of the nicotinic acetylcholine receptor.

Management Efficiency

The company has return on total asset (ROA) of (16.4) % which means that it has lost $16.4 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (26.76) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Entity Summary

IntraCellular Therapies, Inc., a biopharmaceutical company, discovers and develops small molecule drugs for the treatment of neuropsychiatric and neurologic disorders within the central nervous system . Intra Cellular Therapies Inc (ITCI) is traded on NASDAQ in USA. It is located in NEW YORK, U.S.A and employs 37 people. Intra Cellular is listed under Pharmaceutical Products category by Fama And French industry classification.

Did you try this?

Run Fundamentals Comparison Now

Fundamentals Comparison

Compare fundamentals across multiple equities to find investing opportunities
Hide  View All  Next  Launch Fundamentals Comparison
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Intra Cellular Therapies Inc to your portfolio

Top Management

Intra Cellular Thera Leadership Team
Lawrence Wennogle, President, Ph.D
Christopher Alafi, Director
Michael Rawlins, Director
Robert Nostrand, Director
Richard Lerner, Director
Robert Davis, President, Ph.D
Allen Fienberg, Founder, Ph.D
Michael Halstead, SVP
Sharon Mates, Chairman, Ph.D
Juan Sanchez, President
Rory Riggs, Director, MBA
Joel Marcus, Director
Kimberly Vanover, VP, Ph.D
Lawrence Hineline, President, CPA

Stock Performance

Intra Cellular Performance Indicators